Repositorio Dspace

Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma

Mostrar el registro sencillo del ítem

dc.contributor.author Castillo-González, Ana-Cristina
dc.contributor.author Nieto-Cerón, Susana
dc.contributor.author Noguera-Velasco, José-Antonio
dc.contributor.author López-Moreno, María-Fuensanta
dc.contributor.author Cabezas-Herrera, Juan
dc.contributor.author Pelegrín-Hernández, Juan-Pablo
dc.contributor.author Hellín-Meseguer, Diego
dc.contributor.author Montenegro, María-Fernanda
dc.contributor.author Rodríguez-López, José-Neptuno
dc.contributor.author Vidal, Cecilio-J
dc.date.accessioned 2026-10-21T06:10:25Z
dc.date.available 2026-10-21T06:10:25Z
dc.date.issued 2015-12
dc.identifier.citation Castillo-González AC, Nieto-Cerón S, Pelegrín-Hernández JP, Montenegro MF, Noguera JA, López-Moreno MF, et al. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma. BMC Cancer. diciembre de 2015;15(1):385. doi:10.1186/s12885-015-1402-y
dc.identifier.issn 1471-2407
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28728
dc.description.abstract BACKGROUND: In airways, a proliferative effect is played directly by cholinergic agonists through nicotinic and muscarinic receptors activation. How tumors respond to aberrantly activated cholinergic signalling is a key question in smoking-related cancer. This research was addressed to explore a possible link of cholinergic signalling changes with cancer biology. METHODS: Fifty-seven paired pieces of head and neck squamous cell carcinoma (HNSCC) and adjacent non-cancerous tissue (ANCT) were compared for their mRNA levels for ACh-related proteins and ACh-hydrolyzing activity. RESULTS: The measurement in ANCT of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activities (5.416 ± 0.501 mU/mg protein and 6.350 ± 0.599 mU/mg protein, respectively) demonstrated that upper respiratory tract is capable of controlling the availability of ACh. In HNSCC, AChE and BChE activities dropped to 3.584 ± 0.599 mU/mg protein (p = 0.002) and 3.965 ± 0.423 mU/mg protein (p < 0.001). Moreover, tumours with low AChE activity and high BChE activity were associated with shorter patient overall survival. ANCT and HNSCC differed in mRNA levels for AChE-T, ?3, ?5, ?9 and ?2 for nAChR subunits. Tobacco exposure had a great impact on the expression of both AChE-H and AChE-T mRNAs. Unaffected and cancerous pieces contained principal AChE dimers and BChE tetramers. The lack of nerve-born PRiMA-linked AChE agreed with pathological findings on nerve terminal remodelling and loss in HNSCC. CONCLUSIONS: Our results suggest that the low AChE activity in HNSCC can be used to predict survival in patients with head and neck cancer. So, the ChE activity level can be used as a reliable prognostic marker.
dc.language.iso eng
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Acetylcholinesterase/genetics/metabolism
dc.subject.mesh Adult
dc.subject.mesh Aged
dc.subject.mesh Aged, 80 and over
dc.subject.mesh Biomarkers, Tumor/genetics/metabolism
dc.subject.mesh Butyrylcholinesterase/genetics/metabolism
dc.subject.mesh Carcinoma, Squamous Cell/enzymology/mortality/pathology
dc.subject.mesh Disease-Free Survival
dc.subject.mesh Female
dc.subject.mesh Gene Expression
dc.subject.mesh Head and Neck Neoplasms/enzymology/mortality/pathology
dc.subject.mesh Humans
dc.subject.mesh Kaplan-Meier Estimate
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh Prognosis
dc.subject.mesh Proportional Hazards Models
dc.subject.mesh Respiratory Mucosa/enzymology
dc.subject.mesh Young Adult
dc.title Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 25956553
dc.relation.publisherversion https://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1402-y
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1186/s12885-015-1402-y
dc.journal.title Bmc Cancer


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta